Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer letters

Showing results (111-120 of 17,053) with videos related to

Pageof 1,706
Sort By:
Cancer Letters|September 1, 1990
Acute inhibition of DNA synthesis in hamster buccal pouch epithelium exposed to indirect acting carcinogensM Nagabhushan, Y K Ng, R Elias, et al.
Cancer Letters|September 10, 2010
Cetuximab-conjugated magneto-fluorescent silica nanoparticles for in vivo colon cancer targeting and imagingYoung-Seok Cho, Tae-Jong Yoon, Eue-Soon Jang, et al.
Cancer Letters|July 6, 2010
Combating apoptosis and multidrug resistant cancers by targeting lysosomesLine Groth-Pedersen, Marja Jäättelä
Cancer Letters|November 27, 2010
KSHV genotypes A and C are more frequent in Kaposi sarcoma lesions from Brazilian patients with and without HIV infection, respectivelySuzane Ramos da Silva, Ana Paula Ferraz da Silva, Maura Moscardi Bacchi, et al.
Cancer Letters|November 16, 2010
Imatinib treatment in chronic myelogenous leukemia: What have we learned so far?Massimo Breccia, Fabio Efficace, Giuliana Alimena
Cancer Letters|November 17, 2010
Trp-P-1, a carcinogenic heterocyclic amine, inhibits lipopolysaccharide-induced maturation and activation of human dendritic cellsJun Ho Jeon, Sun Kyung Kim, Jintaek Im, et al.
Cancer Letters|December 21, 2010
Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signalingXin He, Yu Wang, Jinhong Zhu, et al.
Cancer Letters|January 4, 2011
Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomasStephan Macher-Goeppinger, Justo Lorenzo Bermejo, Nina Wagener, et al.
Cancer Letters|February 23, 2011
Overexpression of CRKII increases migration and invasive potential in oral squamous cell carcinomaShin-Ichi Yamada, Souichi Yanamoto, Goro Kawasaki, et al.
Cancer Letters|February 22, 2011
Ethyl pyruvate, an anti-inflammatory agent, inhibits tumor angiogenesis through inhibition of the NF-κB signaling pathwayShi-Young Park, Eui-Yeun Yi, Myunghwan Jung, et al.
Pageof 1,706

Showing results (111-120 of 17,053) with videos related to

Sort By:
Pageof 1,706
Cancer Letters|September 1, 1990
Acute inhibition of DNA synthesis in hamster buccal pouch epithelium exposed to indirect acting carcinogensM Nagabhushan, Y K Ng, R Elias, et al.
Cancer Letters|September 10, 2010
Cetuximab-conjugated magneto-fluorescent silica nanoparticles for in vivo colon cancer targeting and imagingYoung-Seok Cho, Tae-Jong Yoon, Eue-Soon Jang, et al.
Cancer Letters|July 6, 2010
Combating apoptosis and multidrug resistant cancers by targeting lysosomesLine Groth-Pedersen, Marja Jäättelä
Cancer Letters|November 27, 2010
KSHV genotypes A and C are more frequent in Kaposi sarcoma lesions from Brazilian patients with and without HIV infection, respectivelySuzane Ramos da Silva, Ana Paula Ferraz da Silva, Maura Moscardi Bacchi, et al.
Cancer Letters|November 16, 2010
Imatinib treatment in chronic myelogenous leukemia: What have we learned so far?Massimo Breccia, Fabio Efficace, Giuliana Alimena
Cancer Letters|November 17, 2010
Trp-P-1, a carcinogenic heterocyclic amine, inhibits lipopolysaccharide-induced maturation and activation of human dendritic cellsJun Ho Jeon, Sun Kyung Kim, Jintaek Im, et al.
Cancer Letters|December 21, 2010
Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signalingXin He, Yu Wang, Jinhong Zhu, et al.
Cancer Letters|January 4, 2011
Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomasStephan Macher-Goeppinger, Justo Lorenzo Bermejo, Nina Wagener, et al.
Cancer Letters|February 23, 2011
Overexpression of CRKII increases migration and invasive potential in oral squamous cell carcinomaShin-Ichi Yamada, Souichi Yanamoto, Goro Kawasaki, et al.
Cancer Letters|February 22, 2011
Ethyl pyruvate, an anti-inflammatory agent, inhibits tumor angiogenesis through inhibition of the NF-κB signaling pathwayShi-Young Park, Eui-Yeun Yi, Myunghwan Jung, et al.
Pageof 1,706